Atika Capital Management LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atika Capital Management LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$7,049,000
-15.6%
38,500
-26.7%
1.38%
-18.4%
Q1 2019$8,350,000
+141.1%
52,500
+144.2%
1.70%
+43.1%
Q1 2018$3,463,000
+250.5%
21,500
+258.3%
1.19%
+210.5%
Q4 2017$988,000
+5.7%
6,000
-60.0%
0.38%
+42.0%
Q3 2017$935,000
+67.9%
15,000
+114.3%
0.27%
+37.9%
Q2 2017$557,000
-12.8%
7,000
-22.2%
0.20%
-37.7%
Q1 2017$639,000
+36.8%
9,000
+12.5%
0.31%
+30.4%
Q4 2015$467,000
-80.6%
8,000
-75.8%
0.24%
-77.9%
Q2 2015$2,409,00033,0001.08%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders